Broselow Tape: How It Works, Accuracy, and Alternatives

The Broselow tape is a color-coded, length-based tool used in pediatric emergencies to rapidly estimate a child’s weight and then guide medication doses, defibrillation energy levels, and equipment sizes. Invented by emergency physicians James Broselow and Robert Luten, it works on a simple principle: a child’s length correlates reasonably well with their weight, and that estimated weight drives every other clinical decision during a resuscitation.¹ The tape is a staple in emergency departments, ambulances, and resuscitation bays worldwide, but its accuracy has been questioned in study after study, and understanding where it works well and where it falls short matters for anyone involved in pediatric care.

How the Tape Actually Works

You lay the tape alongside a child, aligning one end with the top of the head and reading the color zone at the child’s heel. Each color zone corresponds to a predicted weight range, and printed on the tape (or on an accompanying reference sheet) are pre-calculated drug doses, equipment sizes, and fluid volumes matched to that zone. The idea is to eliminate the mental math that slows clinicians down and breeds errors during high-stress resuscitations. The tape is divided into zones for medication doses and eight zones for equipment selection, with each zone spanning a narrow weight range so that the right endotracheal tube, laryngeal mask airway, or IV catheter can be grabbed almost instantly.²

The appeal is obvious. Pediatric patients span a huge range of sizes, from premature neonates to adolescents, and unlike adults, there is no single “standard” dose or tube size. Every drug calculation is weight-dependent. In a cardiac arrest or severe allergic reaction, there is no time to weigh the child on a scale. The Broselow tape gives clinicians a fast, standardized starting point, and American Heart Association guidelines recommend its use as a length-based weight estimation tool.³

How Accurate Is the Weight Estimate

This is where the tape’s reputation gets complicated. A systematic review and meta-analysis found that the weight-estimation accuracy of the tape was suboptimal across all populations studied, with just over half of children receiving an estimate within 10% of their actual weight.⁴ That means nearly half the time, the tape’s estimate was off by more than 10%, which is the threshold many pharmacologists consider clinically meaningful for drug dosing.

A study of over 500 children in the United States found the tape was inaccurate in about 42% of cases. Most of the misses were underestimates: roughly 29% of children weighed more than the tape predicted, while about 13% weighed less. The majority of those discrepancies were off by only one color zone, which limits the practical harm, but a one-zone error still means an incorrect drug dose for that child.⁵ A rural trauma center study painted a similar picture: over half of pediatric trauma patients fell outside the predicted weight range, and among those who deviated, more than three-quarters were heavier than the tape estimated.⁶

The pattern across studies is consistent: in well-nourished Western populations, the tape tends to underestimate weight, especially in older and heavier children. Rising childhood obesity rates are a big part of the explanation. Children today are, on average, heavier for their height than the reference populations the tape was originally calibrated against. For the youngest infants under about 75 centimeters, the tape does reasonably well, matching actual weight about two-thirds of the time. But the children who deviated did so dramatically, sometimes by two or three color zones.⁷

The Problem Flips in Malnourished Populations

If the tape underestimates weight in well-fed children, it does the opposite where malnutrition is common, and the magnitude of the error can be alarming. A study conducted in South Sudan found that among malnourished children, only about 11% had their actual weight fall within the Broselow color zone matching their length. In non-malnourished South Sudanese children, the figure was still only about 27%. The tape overestimated weight by an average of roughly 27% in malnourished children and 17% in non-malnourished children.⁸

Overestimating a child’s weight means overestimating drug doses, and that is where the clinical risk becomes serious. A child who receives a dose of epinephrine or a sedative calculated for a body mass 25% greater than their own faces a real risk of toxicity. The meta-analysis noted that overestimation of weight in low- and middle-income countries was often extreme, signaling a significant potential for harmful medication errors.⁹ This makes the tape particularly unreliable in exactly the settings that lack alternative resources like functioning scales or electronic dosing calculators.

How It Stacks Up Against Age-Based Formulas

Clinicians who do not have a Broselow tape sometimes fall back on age-based formulas to estimate a child’s weight. The most common ones are the APLS formula and the Nelson formula, which use a child’s age in years to calculate a predicted weight. In head-to-head comparisons, the Broselow tape generally performs as well as or better than these formulas, though none of the methods is impressively accurate.

A study in Kenya found that the Broselow tape had a mean percentage difference from actual weight of about negative 2%, compared to about negative 5% for the APLS formula and negative 10% for Nelson’s formulas. The tape consistently came closer to the real weight than the age-based alternatives.¹⁰ A study of Indian children found a near-perfect positive correlation between the Broselow tape and actual weights across all weight ranges, with a mean bias of less than 0.04 kilograms. The APLS and other formula-based methods overestimated weight by two to three kilograms.¹¹

A Ghanaian study comparing several methods found that the 2017 version of the Broselow tape, the original APLS formula, and Nelson’s formula all performed similarly, each getting within 10% of actual weight in roughly 47-51% of children.¹² The bottom line across these studies: the Broselow tape is generally the best of the imperfect options, but its advantage over simple formulas is modest. The real benefit is speed, because looking at a color zone takes seconds, while recalling and computing a formula under stress takes much longer and introduces more opportunities for arithmetic mistakes.

Equipment Sizing

Beyond drug dosing, the tape is used to select the right size of endotracheal tube, the breathing tube placed in the airway during resuscitation. This matters a lot: a tube that is too small leaks air around the seal, and a tube that is too large can damage the delicate tissues of a child’s trachea. The tape’s track record here is mixed but reasonable.

A German study found that the Broselow tape matched the actual tube size used in about 55% of cases and underestimated the needed size in 39%. An age-based formula matched only 41% of the time and overestimated in 57% of cases, a more dangerous direction of error because an oversized tube can cause airway trauma.¹³ An Indian study, however, reported that the tape correctly predicted tube size in about 50% of cases, while an age-based formula was correct about 60% of the time. The tape underestimated tube size in 47% of the Indian children studied.¹⁴

The discrepancy between these two findings reflects the broader theme: the tape was calibrated against North American and European growth data, and children in different populations have different body proportions. Indian children in the study tended to need a different tube size for their length than the tape predicted. This is not a fatal flaw for any single method, since clinicians always have the next size up and down within reach, but it does mean the tape should be treated as a starting estimate rather than a definitive answer.

Where It Genuinely Saves Lives

The tape’s most unambiguous contribution is in reducing medication errors and speeding up drug delivery during resuscitations. Pediatric drug dosing errors are disturbingly common in emergencies, and the Broselow system was designed specifically to reduce them.

A simulation study compared clinicians using color-coded prefilled syringes matched to the Broselow system against clinicians using a conventional setup. The prefilled-syringe group cut median time to drug delivery from about 47 seconds to about 19 seconds per dose, shaving nearly half a minute off each medication administration.¹⁵ Total dosing errors dropped from 19% to 5%, and critical dosing errors dropped from 17% to zero.¹⁶ When seconds matter during a cardiac arrest, getting the right epinephrine dose into a child 28 seconds faster can change the outcome.

That said, the tape alone is not always enough. A study comparing the Broselow system to a competing length-based system (Handtevy) found that for dextrose administration, errors were significantly more frequent with the Broselow tape (about 64% vs. 14%), and time to administration was longer. For epinephrine, the two systems performed similarly.¹⁷ The meta-analysis noted that the tape was frequently used incorrectly in practice and contained insufficient information to function without additional resources.¹⁸ In other words, the tape helps enormously when it is part of a well-designed system with prefilled syringes and trained staff, but handing someone an unfamiliar tape without training and expecting perfect performance is unrealistic.

Practical Pitfalls in Real Emergencies

The tape was designed to be used on a child lying flat on their back, stretched to full length. In a real emergency, children are not always cooperating. They may be sitting up, thrashing, screaming, or curled into a parent’s arms. A study examining the effects of patient position and cooperation on tape accuracy found that suboptimal positioning and lack of cooperation significantly degraded the Broselow tape’s performance, more so than with other weight estimation systems. The tape’s width of about 95 millimeters made it particularly cumbersome and difficult to manipulate on a sitting or uncooperative child.¹⁹

This is an underappreciated weakness. Clinical validation studies are typically done with calm children in controlled settings. The chaotic reality of a pediatric resuscitation, where a toddler with anaphylaxis is being held by a panicked caregiver while the team tries to stretch a tape alongside them, introduces measurement errors that compound the tape’s inherent weight-estimation inaccuracy.

The PAWPER Tape and Other Alternatives

Recognizing the Broselow tape’s limitations, researchers have developed improved versions that try to account for body habitus, essentially the child’s build. The most studied alternative is the PAWPER (Pediatric Advanced Weight Prediction in the Emergency Room) tape, which uses the child’s length plus a visual assessment of their body type to refine the weight estimate.

The results have been consistently better. In the original validation, the PAWPER tape predicted weight within 10% of actual weight in about 89% of children, compared to about 64% for the Broselow tape.²⁰ An Italian validation study found the PAWPER tape was more accurate (75% within 10% of actual weight) and more precise than the Broselow tape (65% within 10%), with the advantage being most pronounced in children who were either underweight or overweight for their height.²¹ A Nepalese study showed similar patterns, with the PAWPER XL tape achieving about 72% accuracy within 10% compared to 63% for the Broselow tape, and 95% within 20% compared to 92%.²²

The PAWPER tape’s advantage is greatest exactly where the Broselow tape struggles most: children who are significantly above or below average weight for their length. For average-weight children, the Broselow tape performs adequately and the two systems converge.²³ The trade-off is that the PAWPER tape requires an extra step, the habitus modifier, which adds a subjective judgment call. In a system that was designed for speed and simplicity, any added complexity carries a cost.

Digital Tools on the Horizon

Another direction is bypassing the physical tape entirely. Researchers have developed a smartphone application called AiRDose that uses augmented reality to measure a child’s length through the phone’s camera and then provides Broselow-based weight estimates, drug doses, defibrillation energies, and equipment sizes.²⁴ The app essentially digitizes the Broselow tape, using the same length-to-weight conversions but removing the need to physically stretch a tape alongside a child. In principle, this could reduce measurement error from positioning difficulties, though the weight estimation itself inherits the same limitations as the underlying Broselow data.

Some countries have taken a different approach altogether, developing region-specific tapes calibrated to local growth data. India, for instance, has developed a Pediatric Advanced Life Support tape using Indian growth references, recognizing that a tape built on American growth curves does not fit Indian children well.²⁵ This is probably the most logical long-term solution: regional tapes that match the children they will actually be used on, rather than a one-size-fits-all tool exported from the United States.

When to Trust It and When to Adjust

For all its flaws, the Broselow tape remains the most widely available and fastest pediatric weight estimation tool in emergency settings. In a true resuscitation, when there is no scale and no time, the tape provides a reasonable starting estimate that is better than guessing. Clinicians who are aware of its tendencies can mentally adjust: in well-nourished Western populations, the tape likely underestimates weight, so rounding up may be appropriate. In settings with high malnutrition prevalence, the tape probably overestimates weight, meaning doses calculated from it may be dangerously high.

If a parent or caregiver is present and knows the child’s recent weight, that information is almost always more reliable than any tape or formula. In simulation studies, even parental estimates perform competitively with the tape for children they know well. The tape is most valuable for the truly unknown child: the unresponsive infant brought in by bystanders, the toddler found alone after a disaster, or any situation where no history is available and every second counts.

The tape’s color-coding system also serves a secondary organizational function that is easy to overlook. Many emergency departments use Broselow-coded drawers or bins, each stocked with the correct equipment sizes for that color zone. A nurse who identifies a child as “yellow zone” can pull an entire drawer of appropriately sized masks, tubes, blades, and prefilled syringes without making independent sizing decisions for each item. This systemic benefit persists even when the weight estimate itself is imperfect, because the equipment in adjacent zones typically overlaps in usability.

Why a Simple Tape Still Matters in a High-Tech World

It is tempting to look at the Broselow tape’s roughly 50-65% accuracy rate and dismiss it as an outdated tool. But that criticism misses the context in which it operates. Pediatric cardiac arrests are rare events, meaning most providers have limited hands-on experience with them. Under extreme cognitive load, with adrenaline flooding the room, even experienced clinicians struggle with basic arithmetic. A tool that gets the answer close enough, fast enough, and without calculation is valuable precisely because it matches the chaos of the environment. The alternative is not a perfectly weighed child on a calibrated scale; the alternative is often a best guess shouted across a room. Measured against that standard, the tape’s imperfect accuracy looks considerably better. The evidence consistently shows it reduces errors and accelerates care when embedded in a well-organized system, and that is ultimately what saves a child’s life during the worst minutes of a pediatric emergency.